TTrialPathMatch Me to Trials
← Back to trials
RecruitingObservational StudyGeniculate ArteryEmbolization

Prospective Observational Study Of Geniculate Artery Embolization For Symptomatic Knee Osteoarthritis In A Cancer Population

Eligible age

40+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

To explore associations with demographics/clinical factors; assess trajectories via annual follow-up; evaluate healthcare utilization and barriers; oversample \>10-year survivors.

Sponsor: M.D. Anderson Cancer Center

You may qualify if…

  • ✓ 1. Age ≥40 years with no upper age restriction, provided performance status permits procedural candidacy
  • ✓ 2. Symptomatic mild-to-severe knee osteoarthritis (Kellgren-Lawrence grade 2-4) on radiographs within 6 months of enrollment
  • ✓ 3. Chronic knee pain (NRS ≥4/10) for ≥3 months despite conservative treatment including steroid injections, physical therapy, and/or analgesic medications
  • ✓ 4. Inadequate candidate for or refusal of surgical intervention (e.g., total knee arthroplasty) due to cancer-related comorbidities, ongoing treatment, or participants preference
  • ✓ 5. Active cancer diagnosis (solid tumor or hematologic malignancy) confirmed at MD Anderson Cancer Center

You may not qualify if…

  • ✕ Active joint infection or suspected septic arthritis
  • ✕ Life expectancy \<6 months
  • ✕ Prior knee arthroplasty in the index knee
  • ✕ Coagulopathy or contraindications to angiography
  • ✕ GFR \<30 mL/min/1.73m²
  • ✕ Peripheral artery disease with stenosis or occlusion of lower extremity vasculature (relative contraindication per SIR standards, given geniculate artery collateral perfusion role)
  • ✕ Radiographically normal knee joint (KL grade 0-1) - alternative etiologies should be sought
  • ✕ Known active autoimmune/inflammatory arthropathy (e.g., rheumatoid arthritis, psoriatic arthritis)

Where it's recruiting

Texas

Houston

Source: ClinicalTrials.gov · NCT07807943 · last updated 2026-09-08